KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Xenon Pharmaceuticals (XENE) over the last 11 years, with Q3 2025 value amounting to 0.01.

  • Xenon Pharmaceuticals' Asset Utilization Ratio changed N/A to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year change of. This contributed to the annual value of 0.01 for FY2022, which is 7062.98% down from last year.
  • As of Q3 2025, Xenon Pharmaceuticals' Asset Utilization Ratio stood at 0.01.
  • In the past 5 years, Xenon Pharmaceuticals' Asset Utilization Ratio registered a high of 0.12 during Q1 2021, and its lowest value of 0.0 during Q2 2023.
  • Its 4-year average for Asset Utilization Ratio is 0.03, with a median of 0.02 in 2022.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Asset Utilization Ratio soared by 7434.08% in 2021 and then plummeted by 9926.85% in 2023.
  • Xenon Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.04 in 2021, then tumbled by 65.19% to 0.01 in 2022, then tumbled by 98.48% to 0.0 in 2023, then soared by 6125.35% to 0.01 in 2025.
  • Its last three reported values are 0.01 in Q3 2025, 0.01 for Q2 2025, and 0.01 during Q1 2025.